Becton, Dickinson and Company BDX BioPharma Systems — Goodwill, Foreign Currency Translation, Gain (Loss)

Other segment segments

Similar metrics at other companies

MLABBiopharmaceutical Development — Goodwill Foreign Currency Translation Gain Loss

$725K+71.0%

BLCOPharmaceuticals — Goodwill, Foreign Currency Translation, Gain (Loss)

$13M+139%

OPKPharmaceutical — Goodwill Foreign Currency Translation Gain Loss

-$1.76M—

LHBiopharma Laboratory Services — Foreign currency impact and other adjustments to goodwill

-$9M—

ASHLife Sciences — Goodwill Foreign Currency Translation Gain Loss

-$5M—

SBH

SBHBeauty Systems Group — Goodwill Foreign Currency Translation Gain Loss

-$253K-717%

Questions, answered.

What is Becton, Dickinson and Company's biopharma systems — goodwill, foreign currency translation, gain (loss)?

Becton, Dickinson and Company (BDX) reported biopharma systems — goodwill, foreign currency translation, gain (loss) of $0 in Q1 2026.

What does biopharma systems — goodwill, foreign currency translation, gain (loss) mean?

This metric tracks the impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency for the BioPharma Systems segment. Because goodwill is often recorded in the functional currency of an acquired entity, changes in global currency markets can cause the reported value to fluctuate without any change in the underlying business performance. It is a non-cash adjustment that reflects the volatility of international operations.